Glymphatic Impairment Associated with Neurocognitive Dysfunction in Moyamoya Disease

Overview

Journal Transl Stroke Res

Publisher Springer

Date 2024 Apr 17

PMID 38630409

Authors

Chaofan Zeng

Yuanren Zhai

Peicong Ge

Chenglong Liu

Xiaofan Yu

Wei Liu

Junsheng Li

Qiheng He

Xingju Liu

Xun Ye

Qian Zhang

Rong Wang

Yan Zhang

Dong Zhang

Jizong Zhao

Affiliations

Soon will be listed here.

Abstract

Glymphatic system alterations have been proved to be associated with cognitive dysfunction in neurodegenerative diseases. The glymphatic pathway has not been elucidated in moyamoya disease (MMD), which was recognized as a chronic hypoperfusion model for neurodegenerative disease. Here, we aimed to investigate the glymphatic system activity and its relation with neurocognition, and associated hallmarks in MMD. We prospectively recruited 30 MMD patients and 30 matched healthy controls (HC). Participants underwent MRI and neurocognition evaluation. The glymphatic function was assessed by diffusion tensor image analysis along perivascular space (DTI-ALPS) index. Gray matter volume (GMV) and microstructural alterations were calculated. Neurodegenerative-related serum biomarkers were examined. The mediation effect of ALPS index in the associations between variables and neurocognition were further explored. A lower ALPS index was identified in patients with MMD (P < 0.001). The decreased ALPS index was significantly correlated with declined neurocognitive performance. Moreover, the reduced ALPS index was notably linked with lower total GMV% and deep GMV% (P < 0.01). Microstructural changes in the periventricular areas were detected and associated with ALPS index in MMD. Serum neurodegenerative biomarkers (ApoE, Aβ40, Aβ42, and Aβ42/Aβ40) were significantly elevated and related to ALPS index. Additionally, the ALPS index significantly mediated the associations of microstructural alterations and ApoE level with neurocognitive dysfunction. The ALPS index was notably lower MMD in patients, suggesting the utility as a marker of potential glymphatic dysfunction. The index acted as a significant mediator in neurocognitive dysfunction. These findings indicated that glymphatic impairment may interact with MMD-related pathophysiological processes.

References

Scott R, Smith E . Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009; 360(12):1226-37. DOI: 10.1056/NEJMra0804622. View

Shi Z, Wen Y, Huang Z, Yu L, Zhang D . Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes. Stroke Vasc Neurol. 2020; 5(1):86-96. PMC: 7213521. DOI: 10.1136/svn-2019-000309. View

Kronenburg A, Deckers P, van den Berg E, van Schooneveld M, Vonken E, van der Zwan A . The profile of cognitive impairment and hemodynamic compromise in moyamoya: a single-center prospective cohort study. J Neurosurg. 2022; 138(1):173-184. DOI: 10.3171/2022.3.JNS212844. View

Hara S, Hori M, Murata S, Ueda R, Tanaka Y, Inaji M . Microstructural Damage in Normal-Appearing Brain Parenchyma and Neurocognitive Dysfunction in Adult Moyamoya Disease. Stroke. 2018; 49(10):2504-2507. DOI: 10.1161/STROKEAHA.118.022367. View

Iliff J, Lee H, Yu M, Feng T, Logan J, Nedergaard M . Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest. 2013; 123(3):1299-309. PMC: 3582150. DOI: 10.1172/JCI67677. View

Taoka T, Masutani Y, Kawai H, Nakane T, Matsuoka K, Yasuno F . Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases. Jpn J Radiol. 2017; 35(4):172-178. DOI: 10.1007/s11604-017-0617-z. View

Carotenuto A, Cacciaguerra L, Pagani E, Preziosa P, Filippi M, Rocca M . Glymphatic system impairment in multiple sclerosis: relation with brain damage and disability. Brain. 2021; 145(8):2785-2795. DOI: 10.1093/brain/awab454. View

Hsu J, Wei Y, Toh C, Hsiao I, Lin K, Yen T . Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease. Ann Neurol. 2022; 93(1):164-174. PMC: 10091747. DOI: 10.1002/ana.26516. View

Xue Y, Zeng C, Ge P, Liu C, Li J, Zhang Y . Association of Variants With Periventricular Anastomosis in Moyamoya Disease. Stroke. 2022; 53(9):2906-2916. DOI: 10.1161/STROKEAHA.121.038066. View

10.

Mugler 3rd J, Brookeman J . Rapid three-dimensional T1-weighted MR imaging with the MP-RAGE sequence. J Magn Reson Imaging. 1991; 1(5):561-7. DOI: 10.1002/jmri.1880010509. View

11.

Setsompop K, Gagoski B, Polimeni J, Witzel T, Wedeen V, Wald L . Blipped-controlled aliasing in parallel imaging for simultaneous multislice echo planar imaging with reduced g-factor penalty. Magn Reson Med. 2011; 67(5):1210-24. PMC: 3323676. DOI: 10.1002/mrm.23097. View

12.

Andersson J, Skare S, Ashburner J . How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage. 2003; 20(2):870-88. DOI: 10.1016/S1053-8119(03)00336-7. View

13.

Andersson J, Sotiropoulos S . An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage. 2015; 125:1063-1078. PMC: 4692656. DOI: 10.1016/j.neuroimage.2015.10.019. View

14.

Zhang H, Schneider T, Wheeler-Kingshott C, Alexander D . NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage. 2012; 61(4):1000-16. DOI: 10.1016/j.neuroimage.2012.03.072. View

15.

Hernandez-Fernandez M, Reguly I, Jbabdi S, Giles M, Smith S, Sotiropoulos S . Using GPUs to accelerate computational diffusion MRI: From microstructure estimation to tractography and connectomes. Neuroimage. 2018; 188:598-615. PMC: 6614035. DOI: 10.1016/j.neuroimage.2018.12.015. View

16.

Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich D . Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage. 2007; 39(1):336-47. PMC: 2724595. DOI: 10.1016/j.neuroimage.2007.07.053. View

17.

Johnson S, McKnight C, Jordan L, Claassen D, Waddle S, Lee C . Choroid plexus perfusion in sickle cell disease and moyamoya vasculopathy: Implications for glymphatic flow. J Cereb Blood Flow Metab. 2021; 41(10):2699-2711. PMC: 8504961. DOI: 10.1177/0271678X211010731. View

18.

Zeppenfeld D, Simon M, Haswell J, DAbreo D, Murchison C, Quinn J . Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains. JAMA Neurol. 2016; 74(1):91-99. DOI: 10.1001/jamaneurol.2016.4370. View

19.

Peng W, Achariyar T, Li B, Liao Y, Mestre H, Hitomi E . Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease. Neurobiol Dis. 2016; 93:215-25. PMC: 4980916. DOI: 10.1016/j.nbd.2016.05.015. View

20.

Liu Z, He S, Xu Z, Duan R, Yuan L, Xiao C . Association between white matter impairment and cognitive dysfunction in patients with ischemic Moyamoya disease. BMC Neurol. 2020; 20(1):302. PMC: 7429789. DOI: 10.1186/s12883-020-01876-0. View